Precision BioSciences, Inc.

NasdaqCM:DTIL 株式レポート

時価総額:US$65.5m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Precision BioSciences バランスシートの健全性

財務の健全性 基準チェック /36

Precision BioSciencesの総株主資本は$74.7M 、総負債は$22.5Mで、負債比率は30.1%となります。総資産と総負債はそれぞれ$165.8Mと$91.1Mです。

主要情報

30.1%

負債資本比率

US$22.49m

負債

インタレスト・カバレッジ・レシオn/a
現金US$123.57m
エクイティUS$74.71m
負債合計US$91.09m
総資産US$165.80m

財務の健全性に関する最新情報

Is Precision BioSciences (NASDAQ:DTIL) Using Debt In A Risky Way?

Mar 14
Is Precision BioSciences (NASDAQ:DTIL) Using Debt In A Risky Way?

Is Precision BioSciences (NASDAQ:DTIL) Weighed On By Its Debt Load?

Dec 08
Is Precision BioSciences (NASDAQ:DTIL) Weighed On By Its Debt Load?

Despite Lacking Profits Precision BioSciences (NASDAQ:DTIL) Seems To Be On Top Of Its Debt

Apr 19
Despite Lacking Profits Precision BioSciences (NASDAQ:DTIL) Seems To Be On Top Of Its Debt

Precision BioSciences (NASDAQ:DTIL) Is Using Debt Safely

Dec 31
Precision BioSciences (NASDAQ:DTIL) Is Using Debt Safely

Recent updates

Analysts Just Made A Meaningful Upgrade To Their Precision BioSciences, Inc. (NASDAQ:DTIL) Forecasts

Aug 06
Analysts Just Made A Meaningful Upgrade To Their Precision BioSciences, Inc. (NASDAQ:DTIL) Forecasts

It's Down 29% But Precision BioSciences, Inc. (NASDAQ:DTIL) Could Be Riskier Than It Looks

Jun 23
It's Down 29% But Precision BioSciences, Inc. (NASDAQ:DTIL) Could Be Riskier Than It Looks

Is Precision BioSciences (NASDAQ:DTIL) Using Debt In A Risky Way?

Mar 14
Is Precision BioSciences (NASDAQ:DTIL) Using Debt In A Risky Way?

Is Precision BioSciences (NASDAQ:DTIL) Weighed On By Its Debt Load?

Dec 08
Is Precision BioSciences (NASDAQ:DTIL) Weighed On By Its Debt Load?

Precision BioSciences appoints chief business officer from within ranks, rejigs co-founders' roles

Sep 02

Precision BioSciences: CAR T Data Updates End Of 2022 And Plenty Of Cash

Aug 16

Precision BioSciences Q2 2022 Earnings Preview

Aug 05

Precision Bio: Another CAR-T Laggard With No Solid Prospects

May 09

Despite Lacking Profits Precision BioSciences (NASDAQ:DTIL) Seems To Be On Top Of Its Debt

Apr 19
Despite Lacking Profits Precision BioSciences (NASDAQ:DTIL) Seems To Be On Top Of Its Debt

Analyst Forecasts Just Became More Bearish On Precision BioSciences, Inc. (NASDAQ:DTIL)

Mar 21
Analyst Forecasts Just Became More Bearish On Precision BioSciences, Inc. (NASDAQ:DTIL)

Precision BioSciences (NASDAQ:DTIL) Is Using Debt Safely

Dec 31
Precision BioSciences (NASDAQ:DTIL) Is Using Debt Safely

Precision BioSciences: Uniquely Positioned

Oct 07

Is Precision BioSciences (NASDAQ:DTIL) A Risky Investment?

Sep 24
Is Precision BioSciences (NASDAQ:DTIL) A Risky Investment?

Precision BioSciences: The Right Profile To Progress

Aug 27

財務状況分析

短期負債: DTILの 短期資産 ( $160.8M ) が 短期負債 ( $33.3M ) を超えています。

長期負債: DTILの短期資産 ( $160.8M ) が 長期負債 ( $114.2M ) を上回っています。


デット・ツー・エクイティの歴史と分析

負債レベル: DTIL総負債よりも多くの現金を保有しています。

負債の削減: DTILの負債対資本比率は、過去 5 年間で0%から30.1%に増加しました。

債務返済能力: DTILの 営業キャッシュフロー はマイナスであるため、負債は十分にカバーされていません。

インタレストカバレッジ: DTILの負債に対する 利息支払いEBIT によって 十分にカバーされている かどうかを判断するにはデータが不十分です。


貸借対照表


健全な企業の発掘